Advanced Search

Digestive Diseases Stocks List

Symbol Grade Name % Change
ICPT F Intercept Pharmaceuticals, Inc. 4.11
IRWD D Ironwood Pharmaceuticals, Inc. 0.99
MCRB F Seres Therapeutics, Inc. -6.87
MIRM F Mirum Pharmaceuticals, Inc. -0.57
BIVI F BioVie Inc. 10.69
View As Page of Charts
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Related Stock Lists: Hepatology Acid Bile Acid Cirrhosis Diarrhea Gastroenterology Liver Liver Disease Liver Diseases Medicine Primary Biliary Cholangitis Acids Alcohol Antibiotic Antimicrobial Resistance Ascites Autoimmune Diseases Cardiovascular Disease Cardiovascular Diseases Cdi

Related ETFs - A few ETFs which own one or more of the above listed Digestive Diseases stocks.

Symbol Grade Name Weight
FBT F First Trust Amex Biotech Index Fund 2.93
BBP D BioShares Biotechnology Products Fund 2.9
ACTV A LeaderShares Activist Leaders ETF 2.89
XBI D SPDR Series Trust SPDR S&P Biotech ETF 2.27
LABD D Direxion Daily S&P Biotech Bear 3X Shares 2.27
View all Digestive Diseases related ETFs...
Compare ETFs
  • Compare ACTV to LABD
  • Compare ACTV to XBI
  • Compare FBT to XBI

    • Recent Signals

    Date Stock Signal Type
    2021-03-08 BIVI Slingshot Bearish Bearish Swing Setup
    2021-03-08 BIVI 200 DMA Resistance Bearish
    2021-03-08 ICPT NR7 Range Contraction
    2021-03-08 ICPT Slingshot Bearish Bearish Swing Setup
    2021-03-08 IRWD 50 DMA Resistance Bearish
    2021-03-08 IRWD 200 DMA Resistance Bearish
    2021-03-08 IRWD Pocket Pivot Bullish Swing Setup
    2021-03-08 IRWD Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
    2021-03-08 MCRB 180 Bearish Setup Bearish Swing Setup
    2021-03-08 MCRB Stochastic Buy Signal Bullish
    2021-03-08 MIRM Slingshot Bearish Bearish Swing Setup

    Recent News for Digestive Diseases Stocks

    Date Stock Title
    Mar 8 MCRB Seres Therapeutics halts SER-401 trial in metastatic melanoma
    Mar 8 MCRB Seres Therapeutics Announces Discontinuation of Enrollment in SER-401 Study in Metastatic Melanoma
    Mar 6 IRWD The Past Week's Most Notable Insider Buys: Editas, Exxon Mobil, Wayfare And More
    Mar 5 MCRB Benzinga's Top Ratings Upgrades, Downgrades For March 5, 2021
    Mar 4 MCRB Seres Therapeutics, Inc. 2020 Q4 - Results - Earnings Call Presentation
    Mar 2 MCRB Seres Therapeutics, Inc. (MCRB) CEO Eric Shaff on Q4 2020 Results - Earnings Call Transcript
    Mar 2 MCRB Seres Therapeutics (MCRB) Reports Q4 Loss, Tops Revenue Estimates
    Mar 2 MCRB Seres Therapeutics EPS misses by $0.02, beats on revenue
    Mar 2 MCRB Seres Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Updates
    Mar 2 MCRB Seres Therapeutics Announces Achievement of Target Enrollment in SER-287 Phase 2b ECO-RESET Study for Ulcerative Colitis
    Mar 2 MCRB Earnings Scheduled For March 2, 2021
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Hepatology Acid Bile Acid Cirrhosis Diarrhea Gastroenterology Liver Liver Disease Liver Diseases Medicine Primary Biliary Cholangitis Acids Alcohol Antibiotic Antimicrobial Resistance Ascites Autoimmune Diseases Cardiovascular Disease Cardiovascular Diseases Cdi

    Karger Publishers (also: Karger Medical and Scientific Publishers, S. Karger AG) is an academic publisher of scientific and medical journals and books. The current CEO is Gabriella Karger.

    More about Digestive Diseases
    Browse All Tags